ImmuPharma plc (AIM:IMM)
4.733
+0.333 (7.56%)
Jun 16, 2026, 12:21 PM GMT
ImmuPharma Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.35 | 0.24 | 0.21 | 0.67 | 1.65 |
Cash & Short-Term Investments | 1.35 | 0.24 | 0.21 | 0.67 | 1.65 |
Cash Growth | 470.81% | 13.63% | -68.78% | -59.51% | -71.86% |
Accounts Receivable | - | - | - | 0.17 | - |
Other Receivables | 0.39 | 0.43 | 0.69 | 1.18 | 1.13 |
Receivables | 0.39 | 0.43 | 0.69 | 1.34 | 1.13 |
Prepaid Expenses | 0.07 | 0.06 | 0.02 | 0.07 | 0.05 |
Other Current Assets | - | 0.15 | 0.43 | 0.25 | 0.51 |
Total Current Assets | 1.81 | 0.88 | 1.34 | 2.34 | 3.35 |
Property, Plant & Equipment | 0.06 | 0.08 | 0.1 | 0.39 | 0.35 |
Long-Term Investments | - | - | 0.64 | 0.69 | 1.42 |
Other Intangible Assets | - | 0.01 | 0.04 | 0.07 | 0.07 |
Long-Term Deferred Charges | - | - | 0.4 | 0.4 | 0.4 |
Other Long-Term Assets | - | - | 0.18 | 0.08 | 0.41 |
Total Assets | 1.88 | 0.98 | 2.72 | 3.97 | 6 |
Accounts Payable | 0.19 | 0.51 | 0.78 | 1.07 | 1.16 |
Accrued Expenses | 0.88 | 0.89 | 0.77 | 0.2 | 0.16 |
Short-Term Debt | - | - | - | 0 | 0 |
Current Portion of Long-Term Debt | - | - | - | - | 0 |
Current Income Taxes Payable | 0.13 | 0.12 | 0.12 | 0.18 | 0.27 |
Total Current Liabilities | 1.19 | 1.52 | 1.67 | 1.45 | 1.58 |
Total Liabilities | 1.19 | 1.52 | 1.67 | 1.45 | 1.58 |
Common Stock | 30.68 | 29.81 | 29.81 | 28.98 | 28.5 |
Additional Paid-In Capital | 31.36 | 29.32 | 29.32 | 28.79 | 27.24 |
Retained Earnings | -67.72 | -65.91 | -64.08 | -61.12 | -56.58 |
Comprehensive Income & Other | 6.37 | 6.24 | 6.01 | 5.87 | 5.26 |
Shareholders' Equity | 0.69 | -0.54 | 1.06 | 2.52 | 4.41 |
Total Liabilities & Equity | 1.88 | 0.98 | 2.72 | 3.97 | 6 |
Total Debt | - | - | - | 0 | 0 |
Net Cash (Debt) | 1.35 | 0.24 | 0.21 | 0.67 | 1.65 |
Net Cash Growth | 470.81% | 13.63% | -68.78% | -59.50% | -68.42% |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Filing Date Shares Outstanding | 502.72 | 416.44 | 416.44 | 333.4 | 284.98 |
Total Common Shares Outstanding | 502.72 | 416.44 | 416.44 | 333.4 | 284.98 |
Working Capital | 0.62 | -0.64 | -0.32 | 0.89 | 1.76 |
Book Value Per Share | 0.00 | -0.00 | 0.00 | 0.01 | 0.02 |
Tangible Book Value | 0.69 | -0.55 | 1.01 | 2.45 | 4.34 |
Tangible Book Value Per Share | 0.00 | -0.00 | 0.00 | 0.01 | 0.02 |
Machinery | 0.15 | 0.14 | 0.19 | 1.26 | 1.1 |